This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masliah, E. Articles by Saitoh, T. Search for Related Content PubMed PubMed Citation Articles by Masliah, E. Articles by Saitoh, T.

American Journal of Pathology, Vol 148, 201-210, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease

E Masliah, A Iwai, M Mallory, K Ueda and T Saitoh
Department of Neurosciences, University of California-San Diego School of Medicine, La Jolla 92093-0624, USA.

We have recently identified, in the brain tissue of patients afflicted with Alzheimer's disease (AD), the non-A beta component of AD amyloid (NAC) as a new constituent of amyloid. NAC is derived from a larger precursor, NACP, a presynaptic protein. To better understand the role of NACP/NAC in the pathogenesis of AD, we used semiquantitative immunoblotting and combined double-immunocytochemistry/laser scanning confocal microscopy to study the concentration and distribution of NACP/NAC in human brain, and compared them to the concentration and distribution of the presynaptic marker synaptophysin and the amyloid marker A beta. The semiquantitative immunoblotting demonstrated that the NACP concentration is slightly increased in the AD frontal cortex without statistical significance, whereas synaptophysin was reduced in its levels in AD. Consequently the proportion of NACP/synaptophysin was more than double in the AD frontal cortex as compared with controls. In the AD neocortex, NACP was colocalized with approximately 80% of the synaptophysin-immunoreactive structures (presumably the presynaptic terminals) and with the dystrophic neuritic component of the plaques. Computer-aided analysis showed that numbers of NACP-immunoreactive structures along synaptophysin-immunoreactive structures were significantly diminished (30 to 40%) in AD. Although the overall numbers of NACP-positive structures were decreased, there was a significant increase in the intensity of NACP-immunoreactivity per structure in AD. This increased intensity of NACP immunoreactivity per structure in AD was not observed with anti-synaptophysin, consistent with immunoblotting-based quantification. Antibodies against NAC immunoreacted with amyloid in 35% of the diffuse plaques and 55% of the mature plaques. Normal aged control brains containing small groups of diffuse plaques were negative with anti-NAC. Double-immunolabeling studies with A beta antibodies showed that NAC immunoreactivity is more abundant in the center portion of amyloid rather than in the periphery. These studies suggest that there is a connection between metabolism of presynaptic proteins and amyloid formation, and that NAC might follow diffuse A beta accumulation resulting in the formation of compact amyloid and mature plaques.

This article has been cited by other articles:

				D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak The Development of Amyloid beta Protein Deposits in the Aged Brain Sci. Aging Knowl. Environ., March 8, 2006; 2006(6): re1 - re1. [Abstract] [Full Text] [PDF]

				C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al. Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy J. Neurosci., November 16, 2005; 25(46): 10689 - 10699. [Abstract] [Full Text] [PDF]

				L. Liao, D. Cheng, J. Wang, D. M. Duong, T. G. Losik, M. Gearing, H. D. Rees, J. J. Lah, A. I. Levey, and J. Peng Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection J. Biol. Chem., August 27, 2004; 279(35): 37061 - 37068. [Abstract] [Full Text] [PDF]

				A. R. Saha, J. Hill, M. A. Utton, A. A. Asuni, S. Ackerley, A. J. Grierson, C. C. Miller, A. M. Davies, V. L. Buchman, B. H. Anderton, et al. Parkinson's disease {alpha}-synuclein mutations exhibit defective axonal transport in cultured neurons J. Cell Sci., March 1, 2004; 117(7): 1017 - 1024. [Abstract] [Full Text] [PDF]

				C. A. da Costa, E. Masliah, and F. Checler {beta}-Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine-induced Caspase 3 Activation: CROSS-TALK WITH {alpha}-SYNUCLEIN AND IMPLICATION FOR PARKINSON'S DISEASE J. Biol. Chem., September 26, 2003; 278(39): 37330 - 37335. [Abstract] [Full Text] [PDF]

				M. HASHIMOTO, E. ROCKENSTEIN, and E. MASLIAH Transgenic Models of {alpha}-Synuclein Pathology: Past, Present, and Future Ann. N.Y. Acad. Sci., June 1, 2003; 991(1): 171 - 188. [Abstract] [Full Text] [PDF]

				Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]

				E. MASLIAH The Role of Synaptic Proteins in Alzheimer's Disease Ann. N.Y. Acad. Sci., December 1, 2000; 924(1): 68 - 75. [Abstract] [Full Text] [PDF]

				M. Shoji, Y. Harigaya, A. Sasaki, K. Uéda, K. Ishiguro, E. Matsubara, M. Watanabe, M. Ikeda, M. Kanai, Y. Tomidokoro, et al. Accumulation of NACP/alpha -synuclein in Lewy body disease and multiple system atrophy J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 605 - 608. [Abstract] [Full Text]

				J. G. Culvenor, C. A. McLean, B. C. V. Campbell, C. L. Masters, Q.-X. Li, P. Jakala, T. Hartmann, and K. Beyreuther The Role of NAC in Amyloidogenesis in Alzheimer’s Disease Am. J. Pathol., February 1, 2000; 156(2): 734 - 736. [Full Text] [PDF]

				J. G. Culvenor, C. A. McLean, S. Cutt, B. C. V. Campbell, F. Maher, P. Jakala, T. Hartmann, K. Beyreuther, C. L. Masters, and Q.-X. Li Non-A{beta} Component of Alzheimer's Disease Amyloid (NAC) Revisited : NAC and {alpha}-Synuclein Are Not Associated with A{beta} Amyloid Am. J. Pathol., October 1, 1999; 155(4): 1173 - 1181. [Abstract] [Full Text] [PDF]

				V. L. Buchman, H. J. A. Hunter, L. G. P. Pinon, J. Thompson, E. M. Privalova, N. N. Ninkina, and A. M. Davies Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System J. Neurosci., November 15, 1998; 18(22): 9335 - 9341. [Abstract] [Full Text] [PDF]

				C. Lavedan The Synuclein Family Genome Res., September 1, 1998; 8(9): 871 - 880. [Abstract] [Full Text]

				B. I. Giasson, I. V. J. Murray, J. Q. Trojanowski, and V. M.-Y. Lee A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of alpha -Synuclein Is Essential for Filament Assembly J. Biol. Chem., January 19, 2001; 276(4): 2380 - 2386. [Abstract] [Full Text] [PDF]

				J. Y. Sung, J. Kim, S. R. Paik, J. H. Park, Y. S. Ahn, and K. C. Chung Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of alpha -Synuclein J. Biol. Chem., July 13, 2001; 276(29): 27441 - 27448. [Abstract] [Full Text] [PDF]